scispace - formally typeset
F

F. Gekeler

Researcher at Ludwig Maximilian University of Munich

Publications -  5
Citations -  1415

F. Gekeler is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 5, co-authored 5 publications receiving 1366 citations.

Papers
More filters
Journal ArticleDOI

Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness (DIDMOAD) Caused by Mutations in a Novel Gene (Wolframin) Coding for a Predicted Transmembrane Protein

TL;DR: One of these genes codes for a predicted transmembrane protein which was expressed in various tissues, including brain and pancreas, and carried loss-of-function mutations in both alleles in Wolfram syndrome patients.
Journal ArticleDOI

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

TL;DR: Creatine improved patient mood and led to a smaller dose increase of dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating Scale scores or dopamine transporter SPECT.
Journal ArticleDOI

A placebo-controlled crossover trial of creatine in mitochondrial diseases.

TL;DR: In this paper, the efficacy and safety of creatine monohydrate in mitochondrial diseases were evaluated in 16 patients with chronic progressive external ophthalmoplegia or mitochondrial myopathy, who were randomized in a crossover design to receive double-blind placebo or 20 g Cr/day for 4 weeks.
Journal ArticleDOI

Diffusion-weighted magnetic resonance imaging during the aura of pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis.

TL;DR: In this paper, the authors performed diffusion-weighted magnetic resonance imaging during the aura of a patient with lymphocytic pleocytosis and found no reduction of water diffusion.